RxDoctor Payments DataLook up a doctor →

Bethany Davis

Psychiatry · Atlanta, GANPI 1881763001

Payments from drug & device makers

$4,416,129in general payments, 2019–2025

Across 827 payments — averaging $5339.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.1M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$702K
  • E.r. Squibb & Sons, L.L.C.$631K
  • Boehringer Ingelheim$607K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$332K
  • Sage Therapeutics, LLC$211K
  • plus $815K from 21 others

What the payments were for

  • Consulting fees$1,80023%
  • Travel & lodging$4,34755%
  • Food & beverage$1,73522%

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,416,129 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Other psychiatry in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →